Breaking News Instant updates and real-time market news.

2020-10-12 15:35:02 GOOS Canada Goose $35.28 / -0.62 (-1.73%) 15:35 10/12/20 10/12 15:35 10/12/20 15:35	Canada Goose put volume heavy and directionally bearish Bearish flow noted in Canada Goose with 1,851 puts trading, or 2x expected. Most active are Jan-21 25 puts and Apr-21 35 calls, with total volume in those strikes near 1,600 contracts. The Put/Call Ratio is 2.10, while ATM IV is up nearly 8 points on the day. Earnings are expected on November 11th.
GOOS Canada Goose $35.28 / -0.62 (-1.73%) 10/07/20 RBC Capital Canada Goose price target raised to C$47 from C$43 at RBC Capital 10/07/20 RBC Capital Canada Goose price target raised to C$47 from C$43 at RBC Capital 10/07/20 Barclays Canada Goose price target raised to $32 from $30 at Barclays 09/30/20 Fly Intel: Top five analyst upgrades

2020-10-12 15:35:02

GOOS

Canada Goose

$35.28 / -0.62 (-1.73%)

15:35

10/12/20

10/12

15:35

10/12/20

15:35

Canada Goose put volume heavy and directionally bearish

Bearish flow noted in Canada Goose with 1,851 puts trading, or 2x expected. Most active are Jan-21 25 puts and Apr-21 35 calls, with total volume in those strikes near 1,600 contracts. The Put/Call Ratio is 2.10, while ATM IV is up nearly 8 points on the day. Earnings are expected on November 11th.

GOOS Canada Goose

$35.28 / -0.62 (-1.73%)

10/07/20 RBC Capital: Canada Goose price target raised to C$47 from C$43 at RBC Capital

10/07/20 RBC Capital: Canada Goose price target raised to C$47 from C$43 at RBC Capital

10/07/20 Barclays: Canada Goose price target raised to $32 from $30 at Barclays

09/30/20: Fly Intel: Top five analyst upgrades

TODAY'S FREE FLY STORIES

Conference/Events	UBS derivatives analyst to hold an analyst/industry conference call » 12:19 03/02/21 03/02 12:19 03/02/21 12:19 Head of Americas… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Technical Analysis	NASDAQ market internals summary » 12:17 03/02/21 03/02 12:17 03/02/21 12:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary 03/01/21 NASDAQ market internals summary 03/01/21 NASDAQ market internals summary
Technical Analysis	NYSE market internals summary » 12:16 03/02/21 03/02 12:16 03/02/21 12:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 11:16 Today NYSE market internals summary 10:16 Today NYSE market internals summary 03/01/21 NYSE market internals summary 03/01/21 NYSE market internals summary
General news	Treasury Action: Treasury yields are being tugged lower » 12:10 03/02/21 03/02 12:10 03/02/21 12:10 Treasury Action: Treasury… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Epizyme expects cash to fund initiatives into 2023 » 12:07 03/02/21 03/02 12:07 03/02/21 12:07 EPZM Epizyme $9.65 / -0.13 (-1.33%) The company reiterated… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events EPZM Epizyme $9.65 / -0.13 (-1.33%) 12:06 Today Epizyme plans to submit IND application for SETD2 in mid-2021 12:05 Today Epizyme to initiate basket trials in additional heme, solid tumors in 2H21 12:04 Today Epizyme reports preliminary data from Phase 1b/2 study of EZH-1101 12:04 Today Epizyme reports preliminary data from Phase 1b/3 study of EZH-302 EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight on Tazverik challenges at Morgan Stanley 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley 02/24/21 Citi Epizyme price target lowered to $27 from $35 at Citi 12/21/20 Jefferies Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/23/21 Epizyme reports Q4 EPS (65c), consensus (58c) 11/06/20 Epizyme reports Q3 EPS (55c), consensus (60c) EPZM Epizyme $9.65 / -0.13 (-1.33%) 01/20/21 Epizyme could be 'vulnerable to an activist investor,' Insightia says EPZM Epizyme $9.65 / -0.13 (-1.33%) 10/05/20 Fly Intel: Wall Street's top stories for Monday 10/05/20 Fly Intel: Wall Street's top stories at midday 10/05/20 Cytokinetics, Epizyme highlighted as possible M&A targets after MyoKardia deal 10:00 Today Epizyme - EPZM

Hot Stocks	Epizyme plans to submit IND application for SETD2 in mid-2021 » 12:06 03/02/21 03/02 12:06 03/02/21 12:06 EPZM Epizyme $9.65 / -0.13 (-1.33%) SETD2 is a histone… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events EPZM Epizyme $9.65 / -0.13 (-1.33%) 12:05 Today Epizyme to initiate basket trials in additional heme, solid tumors in 2H21 12:04 Today Epizyme reports preliminary data from Phase 1b/2 study of EZH-1101 12:04 Today Epizyme reports preliminary data from Phase 1b/3 study of EZH-302 02/23/21 Epizyme sees FY21 non-GAAP adjusted operating expenses $235M-$255M EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight on Tazverik challenges at Morgan Stanley 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley 02/24/21 Citi Epizyme price target lowered to $27 from $35 at Citi 12/21/20 Jefferies Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/23/21 Epizyme reports Q4 EPS (65c), consensus (58c) 11/06/20 Epizyme reports Q3 EPS (55c), consensus (60c) EPZM Epizyme $9.65 / -0.13 (-1.33%) 01/20/21 Epizyme could be 'vulnerable to an activist investor,' Insightia says EPZM Epizyme $9.65 / -0.13 (-1.33%) 10/05/20 Fly Intel: Wall Street's top stories for Monday 10/05/20 Fly Intel: Wall Street's top stories at midday 10/05/20 Cytokinetics, Epizyme highlighted as possible M&A targets after MyoKardia deal 10:00 Today Epizyme - EPZM
Periodicals	Xpeng to offer cheaper battery option for P7 model in China, SCMP reports » 12:06 03/02/21 03/02 12:06 03/02/21 12:06 XPEV Xpeng $32.59 / -2.905 (-8.18%) , TSLA Tesla $704.20 / -14.53 (-2.02%) Xpeng (XPEV), which is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options XPEV TSLA XPEV Xpeng $32.59 / -2.905 (-8.18%) 05:41 Today Xpeng delivers 2.223 Smart EVs in February 02/22/21 Xpeng guided pilot function used for over 1M kilometers since launch 02/01/21 Xpeng delivers 6,015 Smart EVs in January, up 470% 01/26/21 Xpeng announces 'major over-the-air upgrade' for P7 sedan owners in China TSLA Tesla $704.20 / -14.53 (-2.02%) 02/17/21 Cathie Wood says ARK adding to positions in Tesla 02/17/21 EU passenger car registrations down 24.0% in January 02/11/21 EVgo extends nation's largest fast charging network to Tesla drivers 02/10/21 Tesla director Kimbal Musk sells $25.6M in common stock XPEV TSLA XPEV Xpeng $32.59 / -2.905 (-8.18%) 01/28/21 Morgan Stanley starts Xpeng at Overweight on in-house R&D, market potential 01/28/21 Morgan Stanley Xpeng initiated with an Overweight at Morgan Stanley 01/21/21 Deutsche Bank Deutsche puts short-term buy on Xpeng ahead of 'several catalysts' 01/21/21 Deutsche Bank Xpeng named 'Catalyst Call: Buy Idea' at Deutsche Bank TSLA Tesla $704.20 / -14.53 (-2.02%) 02/25/21 Wedbush Wedbush sees limited impact to Tesla from chip-driven factory shutdowns 02/22/21 Wedbush Wedbush estimates Tesla made roughly $1B on bitcoin investment 02/22/21 Argus Livent upgraded to Buy from Hold at Argus 02/16/21 Wedbush India factory 'a smart strategic move' by Tesla, says Wedbush XPEV TSLA XPEV Xpeng $32.59 / -2.905 (-8.18%) 11/12/20 Xpeng sees Q4 revenue RMB 2.2B, up 244% year-over-year 11/12/20 Xpeng reports Q3 EPS (32c), deliveries of 8,578 TSLA Tesla $704.20 / -14.53 (-2.02%) 01/27/21 Tesla reports Q4 non-GAAP EPS 80c, consensus $1.01 01/27/21 Notable companies reporting after market close 10/21/20 Tesla reports Q3 non-GAAP EPS 76c, consensus 56c 10/21/20 Notable companies reporting after market close 09 Dec 27 Aug XPEV TSLA XPEV Xpeng $32.59 / -2.905 (-8.18%) 12/12/20 Nio, Xeng, Li Auto not the next Tesla, Barron's says 12/02/20 House approves bill restricting Chinese firms on U.S exchanges, Bloomberg says 12/01/20 Lucid Motors finishes 1st part of construction on Arizona factory, Electrek says TSLA Tesla $704.20 / -14.53 (-2.02%) 06:20 Today Tesla still relying on supply outside China for Gigafactory 3, DigiTimes reports 02/25/21 Tesla to temporarily halt Model 3 line at California plant, Bloomberg reports 02/23/21 Lucid CEO tells Bloomberg production delay due to Churchill concerns 02/22/21 Tesla stops taking order for base Model Y SUV, Electrek reports XPEV TSLA XPEV Xpeng $32.59 / -2.905 (-8.18%) 02/06/21 Charged: Apple, Hyundai-Kia said to be close to 'Apple Car' deal 02/01/21 Piper more than doubles Tesla target as EV competitors report delivery numbers 02/01/21 Fly Intel: Pre-market Movers 01/28/21 Fly Intel: After-Hours Movers TSLA Tesla $704.20 / -14.53 (-2.02%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/23/21 SPACs slide after Lucid Motors confirms anticipated come-public deal 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 02/13/21 Charged: Tesla discloses $1.5B bitcoin investment 03/08/21 Xpeng - XPEV XPEV TSLA XPEV Xpeng $32.59 / -2.905 (-8.18%) 02/10/21 XPeng call volume above normal and directionally bullish 01/22/21 XPeng call volume above normal and directionally bullish 01/19/21 XPeng call volume above normal and directionally bullish 01/12/21 XPeng call volume above normal and directionally bullish TSLA Tesla $704.20 / -14.53 (-2.02%) 02/24/21 Notable open interest changes for February 24th 02/23/21 Notable open interest changes for February 23rd 02/22/21 Notable open interest changes for February 22nd 02/11/21 Notable open interest changes for February 11th
Hot Stocks	Epizyme to initiate basket trials in additional heme, solid tumors in 2H21 » 12:05 03/02/21 03/02 12:05 03/02/21 12:05 EPZM Epizyme $9.65 / -0.13 (-1.33%) Epizyme will initiate two… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events EPZM Epizyme $9.65 / -0.13 (-1.33%) 12:04 Today Epizyme reports preliminary data from Phase 1b/2 study of EZH-1101 12:04 Today Epizyme reports preliminary data from Phase 1b/3 study of EZH-302 02/23/21 Epizyme sees FY21 non-GAAP adjusted operating expenses $235M-$255M 12/24/20 Epizyme says Boehringer Ingelheim terminated collaboration agreement EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight on Tazverik challenges at Morgan Stanley 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley 02/24/21 Citi Epizyme price target lowered to $27 from $35 at Citi 12/21/20 Jefferies Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/23/21 Epizyme reports Q4 EPS (65c), consensus (58c) 11/06/20 Epizyme reports Q3 EPS (55c), consensus (60c) EPZM Epizyme $9.65 / -0.13 (-1.33%) 01/20/21 Epizyme could be 'vulnerable to an activist investor,' Insightia says EPZM Epizyme $9.65 / -0.13 (-1.33%) 10/05/20 Fly Intel: Wall Street's top stories for Monday 10/05/20 Fly Intel: Wall Street's top stories at midday 10/05/20 Cytokinetics, Epizyme highlighted as possible M&A targets after MyoKardia deal 10:00 Today Epizyme - EPZM
Options	Digital Turbine call volume above normal and directionally bullish » 12:05 03/02/21 03/02 12:05 03/02/21 12:05 APPS Digital Turbine $94.58 / -0.19 (-0.20%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options APPS Digital Turbine $94.58 / -0.19 (-0.20%) 02/26/21 Digital Turbine to acquire AdColony for $350M-$375M 02/26/21 Digital Turbine to acquire AdColony from Otello Corp for $400M consideration 09/09/20 Digital Turbine CEO Stone sells 84,585 common shares APPS Digital Turbine $94.58 / -0.19 (-0.20%) 03/01/21 Craig-Hallum Digital Turbine price target raised to $90 from $80 at Craig-Hallum 03/01/21 Roth Capital Digital Turbine price target raised to $100 from $87 at Roth Capital 02/04/21 Craig-Hallum Digital Turbine price target raised to $80 from $60 at Craig-Hallum 02/04/21 Roth Capital Digital Turbine price target raised to $87 from $70 at Roth Capital APPS Digital Turbine $94.58 / -0.19 (-0.20%) 02/03/21 Digital Turbine sees FY21 adjusted EPS 67c, consensus 63c 02/03/21 Digital Turbine reports Q3 adjusted EPS 21c, consensus 17c 10/29/20 Digital Turbine sees Q3 non-GAAP EPS 15c-16c, consensus 12c 10/29/20 Digital Turbine sees Q3 non-GAAP EPS 15c-16c, consensus 12c APPS Digital Turbine $94.58 / -0.19 (-0.20%) 02/04/21 Fly Intel: Wall Street's top stories for Thursday 02/04/21 Fly Intel: Wall Street's top stories at midday APPS Digital Turbine $94.58 / -0.19 (-0.20%) 02/23/21 Digital Turbine call volume above normal and directionally bullish 02/03/21 Digital Turbine options imply 17.0% move in share price post-earnings 11/18/20 Unusually active option classes on open November 18th 11/05/20 Digital Turbine call volume above normal and directionally bullish
Hot Stocks	Epizyme reports preliminary data from Phase 1b/2 study of EZH-1101 » 12:04 03/02/21 03/02 12:04 03/02/21 12:04 EPZM Epizyme $9.65 / -0.13 (-1.33%) The combination of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events EPZM Epizyme $9.65 / -0.13 (-1.33%) 12:04 Today Epizyme reports preliminary data from Phase 1b/3 study of EZH-302 02/23/21 Epizyme sees FY21 non-GAAP adjusted operating expenses $235M-$255M 12/24/20 Epizyme says Boehringer Ingelheim terminated collaboration agreement 11/06/20 Epizyme sees funds sufficient into at least 2023 EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight on Tazverik challenges at Morgan Stanley 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley 02/24/21 Citi Epizyme price target lowered to $27 from $35 at Citi 12/21/20 Jefferies Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/23/21 Epizyme reports Q4 EPS (65c), consensus (58c) 11/06/20 Epizyme reports Q3 EPS (55c), consensus (60c) EPZM Epizyme $9.65 / -0.13 (-1.33%) 01/20/21 Epizyme could be 'vulnerable to an activist investor,' Insightia says EPZM Epizyme $9.65 / -0.13 (-1.33%) 10/05/20 Fly Intel: Wall Street's top stories for Monday 10/05/20 Fly Intel: Wall Street's top stories at midday 10/05/20 Cytokinetics, Epizyme highlighted as possible M&A targets after MyoKardia deal 10:00 Today Epizyme - EPZM

Hot Stocks	Epizyme reports preliminary data from Phase 1b/3 study of EZH-302 » 12:04 03/02/21 03/02 12:04 03/02/21 12:04 EPZM Epizyme $9.65 / -0.13 (-1.33%) The combination of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/23/21 Epizyme sees FY21 non-GAAP adjusted operating expenses $235M-$255M 12/24/20 Epizyme says Boehringer Ingelheim terminated collaboration agreement 11/06/20 Epizyme sees funds sufficient into at least 2023 10/07/20 Epizyme's Tazverik Phase 2 data featured in two Lancet Oncology publications EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight on Tazverik challenges at Morgan Stanley 02/25/21 Morgan Stanley Epizyme downgraded to Equal Weight from Overweight at Morgan Stanley 02/24/21 Citi Epizyme price target lowered to $27 from $35 at Citi 12/21/20 Jefferies Epizyme downgraded to Hold at Jefferies on lower than consensus Tazverik view EPZM Epizyme $9.65 / -0.13 (-1.33%) 02/23/21 Epizyme reports Q4 EPS (65c), consensus (58c) 11/06/20 Epizyme reports Q3 EPS (55c), consensus (60c) EPZM Epizyme $9.65 / -0.13 (-1.33%) 01/20/21 Epizyme could be 'vulnerable to an activist investor,' Insightia says EPZM Epizyme $9.65 / -0.13 (-1.33%) 10/05/20 Fly Intel: Wall Street's top stories for Monday 10/05/20 Fly Intel: Wall Street's top stories at midday 10/05/20 Cytokinetics, Epizyme highlighted as possible M&A targets after MyoKardia deal 10:00 Today Epizyme - EPZM
Conference/Events	Net 1 UEPS participates in a conference call hosted by B. Riley Securities » 12:02 03/02/21 03/02 12:02 03/02/21 12:02 UEPS Net 1 UEPS $5.36 / +0.02 (+0.37%) Conference call with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events UEPS Net 1 UEPS $5.36 / +0.02 (+0.37%) 02/09/21 Net 1 UEPS appoints Lincoln Mali as South African CEO 02/04/21 Net 1 UEPS sells remaining interest in Bank Frick for $30M UEPS Net 1 UEPS $5.36 / +0.02 (+0.37%) 01/20/21 B. Riley Securities Net 1 UEPS price target raised to $7 from $5 at B. Riley Securities 09/15/20 B. Riley FBR Net 1 UEPS 'stands out as significantly undervalued,' says B. Riley FBR 09/08/20 B. Riley FBR Net 1 UEPS transferred with Buy rating, $5 target at B. Riley FBR UEPS Net 1 UEPS $5.36 / +0.02 (+0.37%) 12/21/20 Fly Insider: Net 1 UEPS, GrafTech among weeks notable insider trades 11/30/20 Fly Insider: Merrimack, Catalent among weeks notable insider trades 10/05/20 Fly Insider: Odonate Therapeutics, Carvana among week's notable insider trades 00:00 Today Net 1 UEPS - UEPS
Hot Stocks	CNH Industrial completes minority investment in Monarch Tractor » 12:02 03/02/21 03/02 12:02 03/02/21 12:02 CNHI CNH Industrial $14.91 / -0.13 (-0.86%) CNH Industrial announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CNHI CNH Industrial $14.91 / -0.13 (-0.86%) 02/24/21 EU commercial vehicle registrations down 7.2% in January 01/26/21 EU commercial vehicle registrations down 4.2% in December 11/30/20 Accenture, Microsoft collaborate with CNH Industrial on connected vehicles 11/25/20 EU commercial vehicle registrations down 1.2% in October CNHI CNH Industrial $14.91 / -0.13 (-0.86%) 02/18/21 Citi CNH Industrial resumed with a Buy at Citi 02/04/21 Vertical Research CNH Industrial upgraded to Buy from Hold at Vertical Research 01/20/21 Vertical Research CNH Industrial initiated with a Hold at Vertical Research 12/15/20 Stifel CNH Industrial price target raised to $12 from $9.50 at Stifel CNHI CNH Industrial $14.91 / -0.13 (-0.86%) 02/03/21 CNH Industrial reports Q4 adjusted EPS 30c, consensus 14c 11/05/20 CNH Industrial reports Q3 adjusted EPS 11c, consensus 2c
Conference/Events	Alpha & Omega participates in a conference call hosted by B. Riley Securities » 12:01 03/02/21 03/02 12:01 03/02/21 12:01 AOSL Alpha & Omega $36.75 / -0.96 (-2.55%) Conference call with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events AOSL Alpha & Omega $36.75 / -0.96 (-2.55%) 11/13/20 Alpha & Omega announces retirement of COO Dr. Yueh-se Ho AOSL Alpha & Omega $36.75 / -0.96 (-2.55%) 02/10/21 B. Riley Securities B. Riley Securities sees interesting opportunities in Skyworks, Silicon Motion 02/08/21 Loop Capital Alpha & Omega price target raised to $45 from $35 at Loop Capital 02/05/21 B. Riley Securities Alpha & Omega price target raised to $44 from $40 at B. Riley Securities 01/25/21 B. Riley Securities Alpha & Omega price target raised to $40 from $35 at B. Riley Securities AOSL Alpha & Omega $36.75 / -0.96 (-2.55%) 02/04/21 Alpha & Omega sees Q3 revenue approximately $157M plus or minus $3M 02/04/21 Alpha & Omega reports Q2 adjusted EPS 65c, consensus 54c 11/05/20 Alpha & Omega sees Q2 revenue $150M-$156M, consensus $141.4M. 11/05/20 Alpha & Omega reports Q1 EPS 55c, consensus 51c AOSL Alpha & Omega $36.75 / -0.96 (-2.55%) 02/04/21 Fly Intel: After-Hours Movers 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 03/15/21 33rd Annual Roth Virtual Conference 00:00 Today Alpha & Omega - AOSL
Conference/Events	Progressive to host investor conference call » 12:01 03/02/21 03/02 12:01 03/02/21 12:01 PGR Progressive $88.50 / +0.88 (+1.00%) Management hosts a 4th… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options PGR Progressive $88.50 / +0.88 (+1.00%) 02/16/21 Progressive to acquire Protective Insurance for $23.30 per share in cash PGR Progressive $88.50 / +0.88 (+1.00%) 02/01/21 Deutsche Bank Progressive price target lowered to $105 from $108 at Deutsche Bank 01/13/21 Gordon Haskett Allstate lowering auto rates by 5% in several states, says Gordon Haskett 01/08/21 Goldman Sachs Progressive downgraded to Sell from Neutral at Goldman Sachs 01/07/21 B. Riley Securities Progressive price target raised to $96 from $88 at B. Riley Securities PGR Progressive $88.50 / +0.88 (+1.00%) 02/17/21 Progressive reports January EPS 95c vs. 52c last year 01/27/21 Progressive reports December EPS $1.20 vs. 78c last year 01/27/21 Progressive reports Q4 EPS $2.85, consensus $1.66 01/26/21 Notable companies reporting before tomorrow's open PGR Progressive $88.50 / +0.88 (+1.00%) 09/22/20 Amazon upgrade, PayPal initiation among today's top calls on Wall Street 13:00 Today Progressive - PGR 13:00 Today Progressive Corporation PGR Progressive $88.50 / +0.88 (+1.00%) 12/07/20 Early notable gainers among liquid option names on December 7th

Hot Stocks	C3.ai falls -14.0% » 12:00 03/02/21 03/02 12:00 03/02/21 12:00 AI C3.ai $104.12 / -16.66 (-13.79%) C3.ai is down -14.0%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options AI C3.ai $104.12 / -16.66 (-13.79%) 10:01 Today C3.ai falls -12.6% 09:47 Today C3.ai falls -11.9% 02/25/21 C3.ai awarded omnibus U.S. patent for end-to-end enterprise AI platform 02/01/21 Shell, C3, Baker Hughes, Microsoft launch Open AI Energy Initiative AI C3.ai $104.12 / -16.66 (-13.79%) 07:31 Today Canaccord C3.ai price target lowered to $120 from $140 at Canaccord 01/04/21 KeyBanc C3.ai initiated with a Sector Weight at KeyBanc 01/04/21 Wedbush Wedbush bullish on C3.ai, initiates with an Outperform 01/04/21 Canaccord C3.ai initiated with a Hold at Canaccord AI C3.ai $104.12 / -16.66 (-13.79%) 03/01/21 C3.ai reports Q3 EPS (13c), consensus (16c) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 09 Dec AI C3.ai $104.12 / -16.66 (-13.79%) 03/01/21 Fly Intel: After-Hours Movers 01/04/21 Fly Intel: Pre-market Movers 12/13/20 Opening Day: Airbnb shares double in IPO, DoorDash soars in debut 09/23/20 Fly Intel: After-Hours Movers 00:00 Today Energy & Power Virtual Conference AI C3.ai $104.12 / -16.66 (-13.79%) 02/09/21 C3 AI call volume above normal and directionally bullish 02/02/21 C3 AI call volume above normal and directionally bullish 01/06/21 Largest borrow rate increases among liquid names 12/15/20 Two new option listings on December 15th
Hot Stocks	Switch falls -14.2% » 12:00 03/02/21 03/02 12:00 03/02/21 12:00 SWCH Switch $15.17 / -2.52 (-14.25%) Switch is down -14.2%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly SWCH Switch $15.17 / -2.52 (-14.25%) 10:02 Today Switch falls -10.7% 09:47 Today Switch falls -11.3% 03/01/21 Switch drops about 7% to $16.51 after reporting mixed Q4 results 09/16/20 Switch appoints Angela Archon to Board of Directors, effective November 4 SWCH Switch $15.17 / -2.52 (-14.25%) 08:21 Today Raymond James Switch downgraded to Outperform from Strong Buy at Raymond James 04:44 Today Raymond James Switch downgraded to Outperform from Strong Buy at Raymond James 02/02/21 Truist sees Switch positioned for long-term growth, starts at Buy 02/02/21 Truist Switch initiated with a Buy at Truist SWCH Switch $15.17 / -2.52 (-14.25%) 03/01/21 Switch sees FY21 revenue $540M-$555M, consensus $588.3M 03/01/21 Switch reports Q4 adjusted EPS 6c, consensus 5c 11/05/20 Switch sees FY20 revenue $510M-$518M, consensus $516.47M 11/05/20 Switch reports Q3 EPS 5c, consensus 4c SWCH Switch $15.17 / -2.52 (-14.25%) 03/01/21 Fly Intel: After-Hours Movers
Hot Stocks	3D Systems falls -14.8% » 12:00 03/02/21 03/02 12:00 03/02/21 12:00 DDD 3D Systems $33.05 / -5.69 (-14.69%) 3D Systems is down… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options DDD 3D Systems $33.05 / -5.69 (-14.69%) 03/01/21 3D Systems sees FY21 gross margin 40%-44% 02/24/21 3D Systems announces introduction of High Speed Fusion 3D printing system 02/11/21 3D Systems selected by Raytheon and DEVCOM as part of research project 02/03/21 3D Systems rises 16.2% DDD 3D Systems $33.05 / -5.69 (-14.69%) 01/29/21 Craig-Hallum 3D Systems downgraded to Hold from Buy at Craig-Hallum 01/29/21 Craig-Hallum 3D Systems downgraded to Hold from Buy at Craig-Hallum 01/25/21 Fly Intel: Top five analyst downgrades 01/25/21 Berenberg 3D Systems downgraded to Hold from Buy at Berenberg DDD 3D Systems $33.05 / -5.69 (-14.69%) 03/01/21 3D Systems reports Q4 EPS 9c, consensus 10c 03/01/21 Notable companies reporting after market close 01/07/21 3D Systems sees Q4 revenue $170M-$176M, consensus $139.91M. 11/05/20 3D Systems reports Q3 EPS (3c), consensus (8c) DDD 3D Systems $33.05 / -5.69 (-14.69%) 01/15/21 Accolade upgrade, Spotify downgrade among today's top calls on Wall Street 01/15/21 Fly Intel: Pre-market Movers 01/07/21 Fly Intel: Wall Street's top stories for Thursday 01/07/21 Fly Intel: Wall Street's top stories at midday 00:00 Today Industrial Technologies Virtual Conference 2021 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 08:30 Today 3D Systems - DDD DDD 3D Systems $33.05 / -5.69 (-14.69%) 01/14/21 3D Systems call volume above normal and directionally bullish 01/07/21 3D Systems call volume above normal and directionally bullish 12/29/20 3D Systems put volume heavy and directionally bearish 12/17/20 3D Systems call volume above normal and directionally bullish
Hot Stocks	Fisker rises 15.0% » 12:00 03/02/21 03/02 12:00 03/02/21 12:00 FSR Fisker $31.68 / +4.32 (+15.79%) Fisker is up 15.0%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options FSR Fisker $31.68 / +4.32 (+15.79%) 03/01/21 Fisker CEO tweets about passing 13,000 Ocean reservations 'fast!' 03/01/21 Fisker falls -9.3% 02/25/21 Fisker up 6% to $22.86 after Q4 report 02/25/21 Fisker sees FY21 operating expenses $210M-$240M FSR Fisker $31.68 / +4.32 (+15.79%) 02/26/21 Morgan Stanley Fisker price target raised to $40 from $27 at Morgan Stanley 02/26/21 Cowen Fisker price target raised to $29 from $22 at Cowen 02/17/21 R.F. Lafferty Fisker initiated with a Buy at R.F. Lafferty 02/11/21 Morgan Stanley Fisker initiated with an Overweight at Morgan Stanley FSR Fisker $31.68 / +4.32 (+15.79%) 02/25/21 Fisker reports Q4 EPS (5c), consensus (5c) 02/25/21 Notable companies reporting after market close FSR Fisker $31.68 / +4.32 (+15.79%) 02/16/21 Churchill Capital soars after Reuters says deal with Lucid Motors is close 02/16/21 Churchill Capital Corp IV near deal to bring Lucid Motors public, Reuters says 01/26/21 Fisker rallies after Seeking Alpha contributor sees 1,000% long-term upside FSR Fisker $31.68 / +4.32 (+15.79%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/25/21 Fly Intel: After-Hours Movers 02/24/21 Fly Intel: Wall Street's top stories for Wednesday 02/24/21 Fly Intel: Wall Street's top stories at midday FSR Fisker $31.68 / +4.32 (+15.79%) 10:25 Today Fisker call volume above normal and directionally bullish 02/26/21 Fisker call volume above normal and directionally bullish 02/24/21 Fisker call volume above normal and directionally bullish 02/12/21 Fisker call volume above normal and directionally bullish
Hot Stocks	Hovnanian rises 18.6% » 12:00 03/02/21 03/02 12:00 03/02/21 12:00 HOV Hovnanian $70.12 / +10.7 (+18.01%) Hovnanian is up 18.6%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Earnings Events HOV Hovnanian $70.12 / +10.7 (+18.01%) 09/04/20 Hovnanian falls -16.2% HOV Hovnanian $70.12 / +10.7 (+18.01%) 09:29 Today Hovnanian sees FY21 revenue $2.65B-$2.8B 09:29 Today Hovnanian sees Q2 revenue $700M-$750M 09:27 Today Hovnanian reports Q1 EPS $2.75 vs. ($1.49) a year ago 12/09/20 Hovnanian reports Q4 EPS $5.54 vs (30c) last year 11:00 Today Hovnanian - HOV 03/30/21 Hovnanian Enterprises Inc.

Hot Stocks	Rocket Companies rises 19.2% » 12:00 03/02/21 03/02 12:00 03/02/21 12:00 RKT Rocket Companies $29.00 / +4.7 (+19.34%) Rocket Companies is up… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options RKT Rocket Companies $29.00 / +4.7 (+19.34%) 10:00 Today Rocket Companies rises 18.7% 09:47 Today Rocket Companies rises 14.6% 02/25/21 Rocket Companies announces special dividend of $1.11 per share 02/25/21 Rocket Companies sees Q1 closed loan volume $98B-$103B RKT Rocket Companies $29.00 / +4.7 (+19.34%) 01/19/21 JPMorgan JPMorgan double downgrades Rocket on more cautious mortgage stance 01/19/21 JPMorgan Rocket Companies downgraded to Underweight from Overweight at JPMorgan 12/17/20 Keefe Bruyette Rocket Companies downgraded to Underperform at Keefe Bruyette 12/14/20 Fly Intel: Top five analyst initiations RKT Rocket Companies $29.00 / +4.7 (+19.34%) 02/25/21 Rocket Companies reports Q4 adjusted EPS $1.14, consensus 87c 02/25/21 Notable companies reporting after market close 11/10/20 Rocket Companies sees Q4 closed loan volume $88B-93B 11/10/20 Rocket Companies reports Q3 EPS 54c, consensus $1.09 06 Aug RKT Rocket Companies $29.00 / +4.7 (+19.34%) 10/01/20 Realtor.com announces new partnership with Rocket Mortgage, Inman reports RKT Rocket Companies $29.00 / +4.7 (+19.34%) 02/25/21 Fly Intel: After-Hours Movers 11/10/20 Fly Intel: After-Hours Movers 09/02/20 Fly Intel: After-Hours Movers RKT Rocket Companies $29.00 / +4.7 (+19.34%) 09:40 Today Unusually active option classes on open March 2nd 03/01/21 Rocket Companies call volume above normal and directionally bullish 03/01/21 Unusually active option classes on open March 1st 02/25/21 Rocket Companies options imply 18.1% move in share price post-earnings
Recommendations	Chorus Aviation price target raised to C$4.75 from C$4 at National Bank » 11:54 03/02/21 03/02 11:54 03/02/21 11:54 CHRRF Chorus Aviation $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals CHRRF Chorus Aviation $0.00 / + (+0.00%) 12/23/20 Trudeau says Canada's suspension of passenger flights from UK extended CHRRF Chorus Aviation $0.00 / + (+0.00%) 11:08 Today TD Securities Chorus Aviation price target raised to C$6 from C$5.50 at TD Securities 02/22/21 CIBC Chorus Aviation price target lowered to C$5.25 from C$5.50 at CIBC 02/22/21 National Bank Chorus Aviation price target raised to C$4 from C$3.60 at National Bank 01/29/21 National Bank Chorus Aviation price target lowered to C$3.60 from C$3.70 at National Bank CHRRF Chorus Aviation $0.00 / + (+0.00%) 11/05/20 Canada close to aid package for airlines, Reuters reports
Recommendations	Telus price target raised to C$34 from C$32 at Scotiabank » 11:51 03/02/21 03/02 11:51 03/02/21 11:51 TU Telus $20.59 / +0.065 (+0.32%) Scotiabank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly TU Telus $20.59 / +0.065 (+0.32%) 02/09/21 Google Cloud, Telus announce strategic alliance 01/25/21 Telus sees 2020 Telus International revenue $1.54B-$1.58B 01/25/21 Telus International launches IPO Roadshow 01/12/21 Telus, RingCentral expand partnership TU Telus $20.59 / +0.065 (+0.32%) 03/01/21 Morgan Stanley Telus International initiated with an Equal Weight at Morgan Stanley 02/12/21 National Bank Telus price target raised to C$29 from C$28 at National Bank 02/12/21 BMO Capital Telus price target raised to C$30 from C$26 at BMO Capital 02/12/21 RBC Capital Telus price target raised to C$29 from C$28 at RBC Capital TU Telus $20.59 / +0.065 (+0.32%) 01/25/21 Telus sees Q4 Telus International revenue $430M-$445M TU Telus $20.59 / +0.065 (+0.32%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech 01/25/21 Fly Intel: Pre-market Movers
Periodicals	New Apple Card users get 6% Daily Cash on Apple purchases, 9to5Mac says » 11:50 03/02/21 03/02 11:50 03/02/21 11:50 AAPL Apple $125.81 / -1.96 (-1.53%) Apple is offering new… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AAPL Apple $125.81 / -1.96 (-1.53%) 02/25/21 Target announces enhanced Apple shopping experience for customers 02/19/21 Luminar, Velodyne Lidar move up after Bloomberg says Apple looking at LiDAR 02/19/21 Energous jumps 53% on Bloomberg report that Apple is working on battery pack 02/18/21 Zynga, Lucasfilm Games announce Star Wars: Hunters for Nintendo Switch AAPL Apple $125.81 / -1.96 (-1.53%) 03/01/21 Wedbush Asia checks bullish for Apple iPhone 12 builds, says Wedbush 03/01/21 JPMorgan Broadcom won new new wireless charging chipset in iPhone 13, says JPMorgan 02/25/21 JPMorgan JPMorgan 'tweaks' EPS estimate for Apple after cut to iPhone forecasts 02/24/21 Piper Sandler Piper sees Apple developing 'full-blown' branded electric vehicle AAPL Apple $125.81 / -1.96 (-1.53%) 01/27/21 Apple reports Q1 EPS $1.70, consensus $1.41 01/27/21 Notable companies reporting after market close 10/29/20 Apple says Q4 results were ahead of expectations 10/29/20 Apple reports Q4 Services revenue $14.55B vs. $12.51B last year AAPL Apple $125.81 / -1.96 (-1.53%) 03/01/21 New EU 'Right to Repair' rules require goods to be repairable, Independent says 03/01/21 All Apple stores in U.S. open for first time since pandemic, CNBC reports 02/24/21 Biden to address chip shortages with executive action, WSJ reports 02/24/21 DOJ investigating Apple's use of 'Sign in With Apple' button, Information says AAPL Apple $125.81 / -1.96 (-1.53%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/25/21 Analysts cut Verizon, AT&T ratings after companies spend big in FCC auction 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 02/19/21 Fly Intel: Wall Street's top stories for Friday 03/17/21 Technology AAPL Apple $125.81 / -1.96 (-1.53%) 08:55 Today Notable open interest changes for March 2nd 08:00 Today Apple call buyer realizes 91% same-day gains 03/01/21 Notable open interest changes for March 1st 02/26/21 Notable open interest changes for February 26th
Recommendations	Neuronetics price target lowered to $25 from $27 at Piper Sandler » 11:50 03/02/21 03/02 11:50 03/02/21 11:50 STIM Neuronetics $14.20 / -2.38 (-14.35%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options STIM Neuronetics $14.20 / -2.38 (-14.35%) 02/11/21 Neuronetics promotes Steve Furlong to CFO 01/19/21 Neuronetics' depression disorder registry reaches 10,000 patients 01/07/21 Neuronetics announces expansion of sales organization 11/23/20 FDA grants clearance for Neuronetics' TouchStar treatment STIM Neuronetics $14.20 / -2.38 (-14.35%) 01/27/21 JMP Securities Neuronetics price target raised to $23 from $15 at JMP Securities 01/22/21 William Blair Neuronetics upgraded to Outperform from Market Perform at William Blair 01/21/21 BTIG Neuronetics price target raised to $21 from $14 at BTIG 01/21/21 Piper Sandler Neuronetics price target raised to $27 from $20 at Piper Sandler STIM Neuronetics $14.20 / -2.38 (-14.35%) 07:36 Today Neuronetics sees Q1 revenue $11M-$12M, consensus $13.56M 07:36 Today Neuronetics sees 2021 revenue $58M-$62M, consensus $62.58M 07:35 Today Neuronetics reports Q4 EPS (19c), consensus (24c) 01/12/21 Neuronetics sees FY20 revenue $48.7M-$49.2M, consensus $46.95M 29 Jan STIM Neuronetics $14.20 / -2.38 (-14.35%) 01/12/21 Fly Intel: After-Hours Movers 11/23/20 Fly Intel: After-Hours Movers 08:30 Today Neuronetics - STIM STIM Neuronetics $14.20 / -2.38 (-14.35%) 09/30/20 Thirteen new option listings and two option delistings on September 30th

Events

Earnings calls, analyst events, roadshows and more

PS
Today at 12:30

Pluralsight, Inc. Firm Sponsored Meetings
Today at 13:00

Fed Governor Speaks on US Economic Outlook Government Event

Virtual Evemt
PGR
Today at 13:00

Progressive - PGR Conference Calls
WORK
Today at 13:00

Slack Technologies, Inc. Firm Sponsored Meetings
PGR
Today at 13:00

Progressive Corporation Firm Sponsored Meetings

Virtual Meeting
SNOW
Today at 13:00

Software & Internet Industry Meetings
Today at 13:00

Consumer Goods Industry Meetings
Today at 14:00

Fed Reserve Bank of San Francisco President Speaks Government Event

Virtual Evemt
CCOI
Today at 14:00

Cogent - CCOI Conference Calls
Today at 14:00

Technology Industry Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright $9.23 1.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	GROY X GROY Gold Royalty IPO Managers: H.C. Wainwright & BMO Capital, CIBC, HAYW, Raymond James, Roth Capital, Scotiabank, Sprott, TD Securities $5.00 16M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB $36.00-38.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler $5.25 Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James $141.28 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson $45.99 4.5M Shares HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler $201.39 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan $62.68 1.75M Shares MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital $84.85 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans $17.00-19.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC $27.97 2.5M Shares SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton $32.22 10.6M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Canada Goose put volume heavy and directionally bearish

TODAY'S FREE FLY STORIES

Get Full Fly Access